Cherwin Catherine H
School of Nursing, University of Wisconsin-Madison, USA.
Oncol Nurs Forum. 2012 Mar;39(2):157-65. doi: 10.1188/12.ONF.157-165.
PURPOSE/OBJECTIVES: To review how gastrointestinal (GI)symptoms are represented within symptom clusters in patients with cancer receiving chemotherapy.
MedLINE, PsycINFO, and CINAHL.
Forty-two symptom clusters containing a GI component emerged. Only four clusters were replicated in different samples; 38 were unique clusters. Thirteen different symptom measurement tools were used across the studies. Nineteen different GI symptoms were measured; however, many chemotherapy- or cancer-related GI symptoms known to be present in this population were missing or underrepresented. Twenty-one of the studies reviewed identified a symptom cluster that was primarily (50% or greater) composed of GI symptoms.
GI symptoms are prevalent in symptom clusters, but those clusters often are inconsistent. One explanation for this finding may be that current symptom measurement tools do not fully address GI symptoms commonly experienced by patients receiving chemotherapy.
Future research should focus on using a comprehensive symptom assessment tool in a homogenous sample of participants who are receiving chemotherapy. Improved measurement of GI symptoms will advance symptom cluster research, which could impact assessment of chemotherapy-related symptoms and development of interventions for symptom clusters.
目的/目标:回顾接受化疗的癌症患者症状群中胃肠道(GI)症状的表现情况。
医学在线数据库(MedLINE)、心理学文摘数据库(PsycINFO)和护理学与健康领域数据库(CINAHL)。
出现了42个包含胃肠道成分的症状群。不同样本中仅重复出现了4个症状群;38个为独特的症状群。各项研究共使用了13种不同的症状测量工具。共测量了19种不同的胃肠道症状;然而,该人群中许多已知的化疗或癌症相关胃肠道症状缺失或未得到充分体现。所回顾的研究中有21项确定了一个主要(50%或更高比例)由胃肠道症状组成的症状群。
胃肠道症状在症状群中普遍存在,但这些症状群往往不一致。这一发现的一个解释可能是,目前的症状测量工具未能充分涵盖接受化疗患者常见的胃肠道症状。
未来的研究应聚焦于在接受化疗的同质样本参与者中使用综合症状评估工具。改善胃肠道症状的测量将推动症状群研究,这可能会影响化疗相关症状的评估以及症状群干预措施的制定。